Plant biotechnology is becoming an accepted avenue for pharmaceutical development. Researchers have engineered plants to grow biomolecules that can be made into therapeutics, including vaccines and monoclonal antibodies. These new technologies hold the promise of more readily bringing treatments to low-to-middle-income countries and providing rapid responses to future pandemics. In this episode, Niki Spahich from The Scientist’s Creative Services Team spoke with Julian Ma, the director of the Institute for Infection and Immunity and professor of molecular immunology at St. George’s Hospital Medical School, to learn more.
The Scientist Speaks is a podcast produced by The Scientist’s Creative Services Team. Our podcast is by scientists and for scientists. Once a month, we bring you the stories behind news-worthy molecular biology research. This month’s episode is sponsored by Daicel Arbor Biosciences.